Clinical Trials

As per the results of international research, which has the distinction of being the world’s first study into second-line human immunodeficiency virus- HIV therapy, 2 newer and simplified options in treatment are as effective as the standards of care...

One of the international studies on kidney cancer recurrence has found that physicians can forecast the likelihood of a disease returning by way of examining DNA mutations in the patients' tumours. The study was undertaken by a team of 44...

Final assessments of a Phase II trial for resectable non-small cell lung cancer found that 60% of patients who had gone on to receive the neoadjuvant nivolumab remained recurrence-free five years following surgery. Overall survival rates were also found...

Biopharma companies as well as policymakers know the significance of assessing medical and drug products across a broad range of racial and ethnic universes so as to fully comprehend the medical effects on patients. This has indeed pushed the...

Representatives from the US FDA Center for Biologics Evaluation and Research Office of Tissues and Advanced Therapies have said that the gene therapy clinical trials depend on the nature of the disease being treated and that the diseases that...

Genenta Science, a clinical-stage biotechnology company, has entered into a development and manufacturing service agreement (MSA) with AGC Biologics S.p.A. to manufacture cell therapy lentivirus-based product for Genenta's ongoing clinical programmes. AGC Biologics offers end-to-end global viral vector and cell...

Syneos Health, the only fully integrated biopharmaceutical solutions organization, announced a strategic partnership with Equicare to use proXimity, an innovative cloud-based software platform that accelerates the transfer of clinical trial subject data from multiple electronic health records (EHR) to...